UNSPSC 51111908: Aminolevulinic acid

This classification denotes a photosensitizing agent with the molecular formula C5H9NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 88755TAZ87, chemically known as pentanoic acid, 5-amino-4-oxo-, hydrochloride but generally known as aminolevulinic acid, which bears US NIH Compound Identifier 137. European Medicines Agency schedules Aminolevulinic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12853MIG.

World Health Organization schedules aminolevulinic acid in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, AMINOLEVULINIC ACID remains the US FDA Preferred Term for this commodity. Aminolevulinic acid bears US NLM identifiers UMLS ID C0002563 and NCI Concept Code C234. SMILES: O=C(CCC(=O)O)CN.

UNSPSC 51111908 Aminolevulinic acid, a Commodity code, represents pharmaceutical raw materials and active pharmaceutical ingredients that state and local governments procure for medical and diagnostic applications. Aminolevulinic acid (ALA) and its derivatives are used primarily in photodynamic therapy (PDT) for dermatological and oncological treatments, as well as in diagnostic fluorescence imaging procedures. State and local purchasing under this code reflects demand from public health departments, state university medical centers, county hospitals, and municipal teaching facilities that stock or manufacture pharmaceutical preparations. The code sits within the broader pharmaceutical ingredients family and captures procurement of the active pharmaceutical ingredient itself rather than finished pharmaceutical products.

The source material provided contains no recent state or local solicitations, awards, or contract opportunities tagged to UNSPSC 51111908 Aminolevulinic acid. Without current opportunity records, the geographic concentration, issuing-body mix, and representative procurement activity cannot be characterized from available data. Firms pursuing state and local business in pharmaceutical ingredients should monitor state procurement portals, university medical system purchasing channels, and public health department RFPs directly rather than relying on historical activity under this particular Commodity code.